Year: 2015


Nov 30 2015

OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors

IRVINE, Calif. and REHOVOT, Israel, Nov. 30, 2015 /PRNewswire/ — OticPharma, Ltd., a privately held specialty pharmaceutical company focused on acquiring and developing innovative therapies for ear, nose, and throat (ENT) disorders, today announced the appointment of Keith A. Katkin as chairman of the company’s board of directors. “We are happy to welcome Keith to the […]

Nov 11 2015

OticPharma Appoints Dr. Catherine C. Turkel as Chief Development Officer

IRVINE, Calif. and REHOVOT, Israel, Nov. 11, 2015 /PRNewswire/ — OticPharma, Inc., a privately held specialty pharmaceutical company focused on acquiring and developing innovative therapies for ear, nose, and throat (ENT) disorders, today announced that it has appointed Catherine C. Turkel, Pharm.D., Ph.D. to the position of senior vice president clinical research and development and chief […]

Nov 02 2015

OticPharma Acquires Novel Otitis Media Program from Otodyne, Inc

IRVINE, Calif. and REHOVOT, Israel, Nov. 2, 2015 /PRNewswire/ — OticPharma, Inc., a privately held specialty pharmaceutical company focused on acquiring and developing innovative therapies for ear, nose, and throat (ENT) disorders, today announced that it has entered into a license agreement with Morristown, New Jersey based drug developer Otodyne, Inc., providing OticPharma with exclusive worldwide […]

Sep 22 2015

OticPharma Announces Key Additions to the Senior Management Team

Christine G. Ocampo named Senior Vice President and Chief Financial Officer Michael P. Cruse named Vice President of Corporate Operations IRVINE, Calif. and REHOVOT, Israel, Sept. 22, 2015 /PRNewswire/ — OticPharma, Ltd., a privately held company focused on acquiring and developing innovative therapies for ear, nose, and throat (ENT) disorders, today announced two new additions to the […]

Sep 03 2015

OticPharma Establishes U.S. Headquarters in Orange County, California

IRVINE, Calif. and REHOVOT, Israel, Sept. 3, 2015 /PRNewswire/ — OticPharma, Ltd., a privately held company focused on acquiring and developing innovative therapies for ear, nose, and throat (ENT) disorders, today announced it has selected the Irvine Company’s Newport Gateway office complex to be the location of its new U.S. headquarters.  OticPharma plans to complete […]